Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Savara Inc (SVRA)  
$2.28 0.07 (3.17%) as of 4:30 Mon 6/30


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 210,690,000
Market Cap: 480.37(M)
Last Volume: 11,363,101 Avg Vol: 11,271,597
52 Week Range: $1.94 - $5.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    : 11.2
Insider 6 Months    : 11.2
Insider 3/6 Months : 22.4
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 208,225 208,225 228,225 3,561,555
Total Buy Value $535,647 $535,647 $594,719 $10,594,709
Total People Bought 3 3 3 13
Total Buy Transactions 3 3 4 14
Total Shares Sold 0 0 0 187,843
Total Sell Value $0 $0 $0 $885,322
Total People Sold 0 0 0 3
Total Sell Transactions 0 0 0 3
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 191
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hawkins Richard J   –       •      –    2025-06-20 4 B $2.04 $98,572 D/D 48,225 115,466 0.01 7%     
   Mccracken Joseph S   –       •      –    2025-05-29 4 B $2.08 $20,825 D/D 10,000 260,837 0.01 -1%     
   Ramsay David A   –       •      –    2025-03-31 4 B $2.78 $416,250 D/D 150,000 2,513,642 0.01 -20%     
   Mccabe Kathleen R. Chief Legal Officer   •       –      –    2025-03-13 3 IO $0.00 $0 D/D 0 558,582 -20%     
   Lutz Robert Matthew Chief Operating Officer   •       –      –    2025-02-13 4 D $2.83 $108,284 D/D (38,263) 361,737     -
   Erickson Anne Chief Business Officer   •       –      –    2024-12-13 4 D $3.21 $58,624 D/D (18,263) 434,672     -
   Pratt Raymond Dennis Chief Medical Officer   •       –      –    2024-12-12 4 A $0.00 $0 D/D 80,000 340,050     -
   Ramsay David A   –       •      –    2024-12-12 4 A $0.00 $0 D/D 40,000 2,363,642     -
   Erickson Anne Chief Business Officer   •       –      –    2024-12-12 4 A $0.00 $0 D/D 100,000 452,935     -
   Mccracken Joseph S   –       •      –    2024-11-19 4 B $2.95 $59,072 D/D 20,000 210,837 0.01 2%     
   Pratt Raymond Dennis Chief Medical Officer   •       –      –    2024-11-10 4 D $3.97 $198,302 D/D (49,950) 260,050     -
   Erickson Anne Chief Business Officer   •       –      –    2024-10-21 4 D $3.57 $1,360 D/D (381) 352,935     -
   Parker Braden C. Chief Commercial Officer   •       –      –    2024-09-25 4 A $0.00 $0 D/D 85,000 85,000     -
   Erickson Anne Chief Business Officer   •       –      –    2024-07-21 4 D $4.47 $1,703 D/D (381) 353,316     -
   Erickson Anne Chief Business Officer   •       –      –    2024-04-21 4 D $4.81 $1,833 D/D (381) 353,697     -
   Erickson Anne Chief Business Officer   •       –      –    2024-03-21 3 IO $0.00 $0 D/D 0 354,078 -7%     
   Elam Nevan C Director   –       •      –    2023-12-28 4 S $4.71 $442,291 D/D (93,843) 22,500 -5%     
   Elam Nevan C Director   –       •      –    2023-12-28 4 OE $0.82 $69,722 D/D 53,758 116,343     -
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2023-12-28 4 S $4.71 $47,131 D/D (10,000) 342,355 -5%     
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-28 4 GD $0.00 $0 D/D 19,000 1,283,674     -
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-28 4 S $4.71 $395,900 D/D (84,000) 1,302,674 -5%     
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2023-12-15 4 GD $0.00 $0 D/D 20,000 352,355     -
   Pratt Raymond Dennis Chief Medical Officer   •       –      –    2023-12-14 4 A $0.00 $0 D/D 150,000 310,000     -
   Sun Ricky   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 22,500     -
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-14 4 A $0.00 $0 D/D 450,000 1,386,674     -

  191 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed